1453504

Naltrexone

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): (5α)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
• Empirical Formula (Hill Notation): C₂₀H₂₃NO₄
• CAS Number: 16590-41-3
• Molecular Weight: 341.40
• NACRES: NA.24

Properties

• grado: pharmaceutical primary standard
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• formato: neat
• InChI: 1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1
• InChI key: DQCKKXVULJGBQN-XFWGSAIBSA-N

Description

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Envase

200 mg

Nota de análisis

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Otras notas

USP issued SDS can be found here.

Sales restrictions may apply.

Safety Information

• pictogramas: GHS07
• Palabra de señalización: Warning
• Frases de peligro: H302 - H336
• Consejos de prudencia: P261 - P264 - P270 - P271 - P301 + P312 - P304 + P340 + P312
• Clasificaciones de peligro: Acute Tox. 4 Oral - STOT SE 3
• Órganos de actuación: Central nervous system
• Código de clase de almacenamiento: 11 - Combustible Solids
• WGK: WGK 3
• Punto de inflamabilidad F: Not applicable
• Punto de inflamabilidad C: Not applicable